5 results on '"Abolnezhadian, Farhad"'
Search Results
2. Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency
- Author
-
Delavari, Samaneh, Abolhassani, Hassan, Abolnezhadian, Farhad, Babaha, Fateme, Iranparast, Sara, Ahanchian, Hamid, Moazzen, Nasrin, Nabavi, Mohammad, Arshi, Saba, Fallahpour, Morteza, Bemanian, Mohammad Hassan, Shokri, Sima, Momen, Tooba, Sadeghi-Shabestari, Mahnaz, Molatefi, Rasol, Shirkani, Afshin, Vosughimotlagh, Ahmad, Safarirad, Molood, Sharifzadeh, Meisam, Pashangzadeh, Salar, Salami, Fereshte, Shirmast, Paniz, Rezaei, Arezou, Moeini Shad, Tannaz, Mohraz, Minoo, Rezaei, Nima, Hammarström, Lennart, Yazdani, Reza, and Aghamohamamdi, Asghar
- Published
- 2021
- Full Text
- View/download PDF
3. Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis
- Author
-
Abolhassani, Hassan, Kiaee, Fatemeh, Tavakol, Marzieh, Chavoshzadeh, Zahra, Mahdaviani, Seyed Alireza, Momen, Tooba, Yazdani, Reza, Azizi, Gholamreza, Habibi, Sima, Gharagozlou, Mohammad, Movahedi, Masoud, Hamidieh, Amir Ali, Behniafard, Nasrin, Nabavi, Mohammamd, Bemanian, Mohammad Hassan, Arshi, Saba, Molatefi, Rasol, Sherkat, Roya, Shirkani, Afshin, Amin, Reza, Aleyasin, Soheila, Faridhosseini, Reza, Jabbari-Azad, Farahzad, Mohammadzadeh, Iraj, Ghaffari, Javad, Shafiei, Alireza, Kalantari, Arash, Mansouri, Mahboubeh, Mesdaghi, Mehrnaz, Babaie, Delara, Ahanchian, Hamid, Khoshkhui, Maryam, Soheili, Habib, Eslamian, Mohammad Hossein, Cheraghi, Taher, Dabbaghzadeh, Abbas, Tavassoli, Mahmoud, Kalmarzi, Rasoul Nasiri, Mortazavi, Seyed Hamidreza, Kashef, Sara, Esmaeilzadeh, Hossein, Tafaroji, Javad, Khalili, Abbas, Zandieh, Fariborz, Sadeghi-Shabestari, Mahnaz, Darougar, Sepideh, Behmanesh, Fatemeh, Akbari, Hedayat, Zandkarimi, Mohammadreza, Abolnezhadian, Farhad, Fayezi, Abbas, Moghtaderi, Mojgan, Ahmadiafshar, Akefeh, Shakerian, Behzad, Sajedi, Vahid, Taghvaei, Behrang, Safari, Mojgan, Heidarzadeh, Marzieh, Ghalebaghi, Babak, Fathi, Seyed Mohammad, Darabi, Behzad, Bazregari, Saeed, Bazargan, Nasrin, Fallahpour, Morteza, Khayatzadeh, Alireza, Javahertrash, Naser, Bashardoust, Bahram, Zamani, Mohammadali, Mohsenzadeh, Azam, Ebrahimi, Sarehsadat, Sharafian, Samin, Vosughimotlagh, Ahmad, Tafakoridelbari, Mitra, Rahimi, Maziar, Ashournia, Parisa, Razaghian, Anahita, Rezaei, Arezou, Mamishi, Setareh, Parvaneh, Nima, Rezaei, Nima, Hammarström, Lennart, and Aghamohammadi, Asghar
- Published
- 2018
- Full Text
- View/download PDF
4. Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19.
- Author
-
Abolhassani, Hassan, Delavari, Samaneh, Landegren, Nils, Shokri, Sima, Bastard, Paul, Du, Likun, Zuo, Fanglei, Hajebi, Reza, Abolnezhadian, Farhad, Iranparast, Sara, Modaresi, Mohammadreza, Vosughimotlagh, Ahmad, Salami, Fereshte, Aranda-Guillén, Maribel, Cobat, Aurélie, Marcotte, Harold, Zhang, Shen-Ying, Zhang, Qian, Rezaei, Nima, and Casanova, Jean-Laurent
- Abstract
Most severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected individuals are asymptomatic or only exhibit mild disease. In about 10% of cases, the infection leads to hypoxemic pneumonia, although it is much more rare in children. We evaluated 31 young patients aged 0.5 to 19 years who had preexisting inborn errors of immunity (IEI) but lacked a molecular diagnosis and were later diagnosed with coronavirus disease 2019 (COVID-19) complications. Genetic evaluation by whole-exome sequencing was performed in all patients. SARS-CoV-2–specific antibodies, autoantibodies against type I IFN (IFN-I), and inflammatory factors in plasma were measured. We also reviewed COVID-19 disease severity/outcome in reported IEI patients. A potential genetic cause of the IEI was identified in 28 patients (90.3%), including mutations that may affect IFN signaling, T- and B-cell function, the inflammasome, and the complement system. From tested patients 65.5% had detectable virus-specific antibodies, and 6.8% had autoantibodies neutralizing IFN-I. Five patients (16.1%) fulfilled the diagnostic criteria of multisystem inflammatory syndrome in children. Eleven patients (35.4%) died of COVID-19 complications. All together, at least 381 IEI children with COVID-19 have been reported in the literature to date. Although many patients with asymptomatic or mild disease may not have been reported, severe presentation of COVID-19 was observed in 23.6% of the published cases, and the mortality rate was 8.7%. Young patients with preexisting IEI may have higher mortality than children without IEI when infected with SARS-CoV-2. Elucidating the genetic basis of IEI patients with severe/critical COVID-19 may help to develop better strategies for prevention and treatment of severe COVID-19 disease and complications in pediatric patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Clinical heterogeneity in families with multiple cases of inborn errors of immunity.
- Author
-
Delavari, Samaneh, Rasouli, Seyed Erfan, Fekrvand, Saba, Chavoshzade, Zahra, Mahdaviani, Seyed Alireza, Shirmast, Paniz, Sharafian, Samin, Sherkat, Roya, Momen, Tooba, Aleyasin, Soheila, Ahanchian, Hamid, Sadeghi-Shabestari, Mahnaz, Esmaeilzadeh, Hossein, Barzamini, Sahar, Tarighatmonfared, Fateme, Salehi, Helia, Esmaeili, Marzie, Marzani, Zahra, Fathi, Nazanin, and Abolnezhadian, Farhad
- Subjects
- *
SEVERE combined immunodeficiency , *DELAYED diagnosis , *IMMUNITY , *HETEROGENEITY , *GENETIC variation , *GENETIC mutation - Abstract
Inborn errors of immunity (IEI) are a diverse range of genetic immune system illnesses affecting the innate and/or adaptive immune systems. Variable expressivity and incomplete penetrance have been reported in IEI patients with similar clinical diagnoses or even the same genetic mutation. Among all recorded patients in the national IEI registry, 193 families with multiple cases have been recognized. Clinical, laboratory and genetic variability were compared between 451 patients with different IEI entities. The diagnosis of the first children led to the earlier diagnosis, lower diagnostic delay, timely treatment and improved survival in the second children in the majority of IEI. The highest discordance in familial lymphoproliferation, autoimmunity and malignancy were respectively observed in STK4 deficiency, DNMT3B deficiency and ATM deficiency. Regarding immunological heterogeneity within a unique family with multiple cases of IEI, the highest discordance in CD3+, CD4+, CD19+, IgM and IgA levels was observed in syndromic combined immunodeficiencies (CID), while non-syndromic CID particularly severe combined immunodeficiency (SCID) manifested the highest discordance in IgG levels. Identification of the first ATM-deficient patient can lead to improved care and better survival in the next IEI children from the same family. Intrafamilial heterogeneity in immunological and/or clinical features could be observed in families with multiple cases of IEI indicating the indisputable role of appropriate treatment and preventive environmental factors besides specific gene mutations in the variable observed penetrance or expressivity of the disease. This also emphasizes the importance of implementing genetic evaluation in all members of a family with a history of IEI even if there is no suspicion of an underlying IEI as other factors besides the underlying genetic defects might cause a milder phenotype or delay in presentation of clinical features. Thus, affected patients could be timely diagnosed and treated, and their quality of life and survival would improve. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.